The role of mastocytosis in anaphylaxis;Znaczenie mastocytozy w reakcjach anafilaktycznych

Postepy Dermatologii I Alergologii

Volumn 23, Issue 1, 2006, Pages 17-20

  Marciniak, Joanna ^a   Jutel, Marek ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Anaphylaxis; Insect venom hypersensitivity; Mastocytosis; Specific immunotherapy; Tryptase

Indexed keywords

ALLERGEN; HEPARIN; HISTAMINE; HYMENOPTERA VENOM; PROSTAGLANDIN D2; TRYPTASE; VACCINE;

ANAPHYLAXIS; BONE MARROW BIOPSY; CELL PROLIFERATION; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME BLOOD LEVEL; ENZYME RELEASE; FATALITY; HUMAN; HYPERSENSITIVITY REACTION; IMMUNOTHERAPY; INSECT ALLERGY; MAST CELL; MAST CELL DEGRANULATION; MASTOCYTOSIS; REVIEW; RISK FACTOR; SKIN BIOPSY;

EID: 33644963900     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Akin C, Metcalfe DD. Systemic mastocytosis. Annu Rev Med 2004; 55: 419-32.
2. Akin C, Metcalfe DD. The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 2004; 114: 13-9.
3. Mastocytozy. W: Dermatologia. Braun-Falco O i wsp.; red. nauk. wyd. pol. Gliński W, Wolska H, Zaborowski P. Wydawnictwo Czelej, Lublin 2002.
4. Vlieg-Boerstra BJ, van der Heide S, Oude Elberink JN, et al. Mastocytosis and adverse reactions to biogenic amines and histamine-releasing foods: what is the evidence? Neth J Med 2005; 63: 244-9.
5. Małolepszy J, Jutel M. Anafilaksja. W: Immunologia kliniczna. Kowalski ML (red.). Mediton. Łódź 2000.
6. Hartmann K, Henz BM. Classification of cutaneous mastocytosis: a modified consensus proposal. Leuk Res 2002; 26: 483-4.
7. Valent P, Horny H, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603-25.
8. Golkar L, Bernhard JD. Mastocytosis. Lancet 1997; 349: 1379-85.
9. Hartmann K, Henz BM. Mastocytosis: recent advances in defining the disease. Br J Dermatol 2001; 144: 682-95.
10. Escribano L, Akin C, Castells M, et al. Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol 2002; 81: 677-90.
11. Haeberli G, Brönnimann M, Hunziker T, et al. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003; 33: 1216-20.
12. Ludolph-Hauser D, Ruëff F, Fries C, et al. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001; 357: 361-2.
13. Valent P, Akin C, Sperr W, et al. Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 2005; 46: 35-48.
14. Williams A, Krishna T, Frew A. Systemic mastocytosis. Lancet 2002; 360: 1611.
15. Almahroos M, Kurban AK. Management of mastocytosis. Clin Dermatol 2003; 21: 274-7.
16. Butterfield JH, Tefferi A, Kozuh GF. Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long - term follow-up of a case. Leuk Res 2005; 29: 131-4.
17. Fricker M, Helbling A, Schwartz L, et al. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 1997; 100: 11-5.
18. Oude Elberink JN, de Monchy JG, Kors JW, et al. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol 1997; 99: 153-4.
19. Krishna MT, Fearby S, Annila I, et al. Hymenoptera stings and serum tryptase. Lancet 2001; 357: 1527-8.